Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Author(s): Golshayan AR | Antonarakis ES
Volume: 2013
Issue: default
Year: 2013

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Author(s): Chavez JC | Sahakian E | Pinilla-Ibarz J
Volume: 2013
Issue: default
Year: 2013

An evidence-based review of obatoclax mesylate in the treatment of hematological malignancies

Author(s): Goard CA | Schimmer AD
Volume: 2013
Issue: default
Year: 2013

Lixivaptan – an evidence-based review of its clinical potential in the treatment of hyponatremia

Author(s): Bowman BT | Rosner MH
Volume: 2013
Issue: default
Year: 2013

Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis

Author(s): Botrel TEA | Clark O | Pompeo ACL | Bretas FFH | Sadi MV | Ferreira U | dos Reis RB
Volume: 2013
Issue: default
Year: 2013

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Author(s): Schaller SJ | Fink H
Volume: 2013
Issue: default
Year: 2013

Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation

Author(s): Lee N | Wald A
Volume: 2012
Issue: default
Year: 2012

Rindopepimut: an evidence-based review of its therapeutic potential in the treatment of EGFRvIII-positive glioblastoma

Author(s): Babu R | Adamson DC
Volume: 2012
Issue: default
Year: 2012

Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action

Author(s): Zema MJ
Volume: 2012
Issue: default
Year: 2012

An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy

Author(s): Watkins RR | Lemonovich TL | File Jr TM
Volume: 2012
Issue: default
Year: 2012

An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation

Author(s): Deedwania P | Huang GW
Volume: 2012
Issue: default
Year: 2012

Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation

Author(s): McCarty EJ | Dinsmore WW
Volume: 2012
Issue: default
Year: 2012

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II

Author(s): Floccard B | Hautin E | Bouillet L | Coppere B | Allaouchiche B
Volume: 2012
Issue: default
Year: 2012

An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease

Author(s): Hollak CE
Volume: 2012
Issue: default
Year: 2012

Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide

Author(s): Kleinberg L
Volume: 2012
Issue: default
Year: 2012

Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review

Author(s): Kirkby S | Novak K | McCoy K
Volume: 2011
Issue: default
Year: 2011

Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Author(s): Bernardo Lombo | José G Díez
Volume: 2011
Issue: default
Year: 2011

Plerixafor for autologous CD34+ cell mobilization

Author(s): Huda Salman | Hillard M Lazarus
Volume: 2011
Issue: default
Year: 2011

Lixisenatide: evidence for its potential use in the treatment of type 2 diabetes

Author(s): Barnett AH
Volume: 2011
Issue: default
Year: 2011

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Author(s): Jain S | Diefenbach C | Zain J | O'Connor OA
Volume: 2011
Issue: default
Year: 2011

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Author(s): Eliana Krulig | Kenneth B Gordon
Volume: 2010
Issue: default
Year: 2010

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Author(s): Rossana Berardi | Azzurra Onofri | Mirco Pistelli | et al
Volume: 2010
Issue: default
Year: 2010

Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

Author(s): Patrick Langford | Paul Chrisp
Volume: 2010
Issue: default
Year: 2010

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Author(s): Sonia Okuyama | Rene Gonzalez | Karl D Lewis
Volume: 2010
Issue: default
Year: 2010

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Author(s): Markos Poulopoulos | Cheryl Waters
Volume: 2010
Issue: default
Year: 2009

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Author(s): Renee M Sullivan | Brian Olshansky
Volume: 2010
Issue: default
Year: 2010

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Author(s): Kristen Kulasa | Steven Edelman
Volume: 2010
Issue: default
Year: 2010

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Author(s): Elias Jabbour | Jorge Cortes | Hagop Kantarjian
Volume: 2009
Issue: default
Year: 2009

Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Author(s): Kavya Ramkumar | Nouri Neamati
Volume: 2009
Issue: default
Year: 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Author(s): Hans-Jürgen Stellbrink
Volume: 2009
Issue: default
Year: 2009

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Author(s): Ayman I Omar | Warren P Mason
Volume: 2009
Issue: default
Year: 2009

Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Author(s): Melissa Li-Ng | Joseph G Verbalis
Volume: 2009
Issue: default
Year: 2009

Golimumab: A novel human anti-TNF-α monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis

Author(s): Jonathan Kay | Mahboob U Rahman
Volume: 2009
Issue: default
Year: 2009

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Author(s): Daniel Z Lieberman | Suena H Massey
Volume: 2009
Issue: default
Year: 2009

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Author(s): Kai M Beeh | Jutta Beier
Volume: 2009
Issue: default
Year: 2009

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Author(s): Paul Richardson | Constantine Mitsiades | Jacob Laubach | et al
Volume: 2009
Issue: default
Year: 2009

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Author(s): Peter Deibert | Carola Xander | Hubert E Blum | et al
Volume: 2009
Issue: default
Year: 2009

Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis

Author(s): Stephen T Sonis
Volume: 2009
Issue: default
Year: 2009

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Author(s): Hari A Deshpande, Scott Gettinger | Julie Ann Sosa
Volume: 2009
Issue: default
Year: 2009

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Author(s): Jean-Marie Krzesinski | Eric P Cohen
Volume: 2009
Issue: default
Year: 2009

Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis

Author(s): Troels Herlin
Volume: 2009
Issue: default
Year: 2009

Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Author(s): Ibrahim Shah | Shakeel O Khan | Surender Malhotra | Tim Fischell
Volume: 2009
Issue: default
Year: 2009

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect

Author(s): E Michael Lewiecki
Volume: 2009
Issue: default
Year: 2009

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Author(s): Angelo L Gaffo | Kenneth G Saag
Volume: 2009
Issue: default
Year: 2009

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Author(s): Katherine A Thornton
Volume: 2009
Issue: default
Year: 2009

Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Author(s): Luigi Gennari | Daniela Merlotti | Vincenzo De Paola | Ranuccio Nuti
Volume: 2009
Issue: default
Year: 2009

Agomelatine: The evidence for its place in the treatment of depression

Author(s): Daniela Eser | Thomas C Baghai | Hans-Jürgen Möller
Volume: 2009
Issue: default
Year: 2009

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Author(s): Louise Profit | Paul Chrisp | Carole Nadin
Volume: 2008
Issue: Issue 1
Year: 2008

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome

Author(s): Arash Aghel | W. H. Wilson Tang
Volume: 2008
Issue: Issue 1
Year: 2008

Omalizumab: the evidence for its place in the treatment of allergic asthma

Author(s): Diarmuid M. McNicholl | Liam G. Heaney
Volume: 2008
Issue: Issue 1
Year: 2008